Clinical Trial Update: An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Cell Transfusions Due to Beta (β) Thalassemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing luspatercept to placebo in adults with beta-thalassemia requiring regular red blood cell transfusions; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Luspatercept (luspatercept)

Snippet

Sponsor: Celgene | Conditions: Erythrocyte Transfusion, Beta-Thalassemia | Phase 3 | Status: COMPLETED | Results posted: 2020-01-27